MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis

OBJECTIVE: The SNP309 polymorphism (T-G) in the promoter of MDM2 gene has been reported to be associated with enhanced MDM2 expression and tumor development. Studies investigating the association between MDM2 SNP309 polymorphism and endometrial cancer risk reported conflicting results. We performed...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Peng, Qiliu, Mo, Cuiju, Qin, Aiping, Lao, Xianjun, Chen, Zhiping, Sui, Jingzhe, Wu, Junrong, Zhai, Limin, Yang, Shi, Qin, Xue, Li, Shan
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2013
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4029393/
https://ncbi.nlm.nih.gov/pubmed/24423195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-32-85
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky